Evidence map›Paper›PMID 35267206›Full record

Trial reportThe Medical journal of Australia2022

Offering mailed nicotine replacement therapy and Quitline support before elective surgery: a randomised controlled trial.

Ashley R Webb, Lisa Coward, Darshana Meanger, Samuel Leong, Sarah L White, Ron Borland

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The Medical journal of Australia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Pharmacist E-script transcription service initiated nicotine replacement therapy uptake in pre-admission clinic: A pilot study.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Ashley R WebbPeninsula Health, Melbourne, VIC.ORCID 0000-0002-9037-158X
Lisa CowardPeninsula Health, Melbourne, VIC.
Darshana MeangerPeninsula Health, Melbourne, VIC.
Samuel LeongPeninsula Health, Melbourne, VIC.
Sarah L WhiteQuit Victoria, Melbourne, VIC.ORCID 0000-0001-5878-8927
Ron BorlandThe University of Melbourne, Melbourne, VIC.

Funding

Wellcome Trust 102209
6 · The paper itself

Abstract

objectiveTo assess whether offering free mailed nicotine replacement therapy (NRT) and telephone counselling to smokers on elective surgery waiting lists increases quitting before surgery. DESIGN,

settingRandomised, controlled trial at Frankston Hospital, a public tertiary referral hospital in Melbourne.

participantsAdult smokers added to elective surgery waiting lists for operations at least ten days in the future, 1 April 2019 - 3 April 2020.

interventionIn addition to normal care, intervention participants received a brochure on the risks of low frequency smoking, an offer of Quitline call-back registration, and an offer of mailed NRT according to reported daily smoking: 1-9 cigarettes/day, 2 mg lozenges; 10-15/day, 7-14 mg patches [three weeks] and 2 mg lozenges; > 15/day, 7-21 mg patches [five weeks] and 2 mg lozenges.

main outcome measuresPrimary outcome: quitting at least 24 hours before surgery, verified by exhaled carbon monoxide testing. SECONDARY OUTCOMES: quitting at least four weeks before surgery, adverse events, and (for those who had quit before surgery) abstinence three months after surgery.

resultsOf 748 eligible participants (control, 363; intervention, 385), 516 (69%) had undergone elective surgery when the trial was terminated early (for COVID-19-related reasons) (intervention group, 274; control group, 242). 122 of the 385 intervention participants (32%) had accepted the offer of cessation support. The proportions of intervention participants who quit at least 24 hours before surgery (18% v 9%; odds ratio [OR], 1.97; 95% CI, 1.22-3.15) or at least four weeks before surgery (9% v 4%; OR, 2.20; 95% CI, 1.08-4.50) were larger than for the control group. Three months after surgery, 27 of 58 intervention (47%) and 12 of 25 control participants (48%) who quit before surgery reported not smoking in the preceding seven days. No major adverse events were reported.

conclusionUptake of free mailed NRT and Quitline support by smokers on elective surgery waiting lists was good, and offering additional support was associated with higher proportions of smokers quitting before surgery.

trial registrationAustralian New Zealand Clinical Trials Registry, ACTRN12619000032156 (prospective).

Indexed as

COVID-19Smoking CessationAdultAustraliaHumansProspective StudiesTobacco Use Cessation DevicesDelivery of healthcareEducation, public healthHealth promotionHealth services researchHospital medicinePerioperative carePrehospital carePreventive health servicesSmokingTreatment outcome

Identifiers

PMID35267206
PMCPMC9314866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.